Status:
WITHDRAWN
Feasibility of Ultra-sound Guided Radiofrequency Ablation in the Management of Head and Neck Neoplasia.
Lead Sponsor:
Johns Hopkins University
Conditions:
Head and Neck Neoplasia
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
To study the feasibility of Radiofrequency ablation (RFA) via ultrasound guidance in the management of head and neck neoplasia.
Detailed Description
The study evaluates the feasibility of radio-frequency ablation in the management of head and neck neoplasia.
Eligibility Criteria
Inclusion
- Patients with head and neck neoplasia.
Exclusion
- When the patient does not meet the inclusion criteria.
- When the patient has a contra-indication of surgery or anesthesia.
- If the patient refuses involvement in the study.
Key Trial Info
Start Date :
November 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 18 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00381225
Start Date
November 1 2006
End Date
March 18 2008
Last Update
September 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins University School of Medicine, Department of Otolaryngology-Head and Neck Surgery
Baltimore, Maryland, United States, 21287